|
|
|
Pharmaceutical Education Associates, The Westin Grand Hotel, Washington, DC
February 26-27, 2004
This exclusive event addresses critical issues including: • FDA Policies Regarding Off-Label Activity • Recent Enforcement of FDA Off-Label Regulations • Identifying False Claims and Safe Harbors • Essential Postmarket Risk Preventing Measures • Court Ruling on First Amendment Rights • Legal Implications Beyond the FDA Regulations • Assessment of Health Outcomes for Off-Label Usage • …and much more!Don’t Miss the Pre-Conference Workshop Managing Interactions between Pharmaceutical Manufacturers and Healthcare Professionals Facilitated by Alan G. Minsk, Partner, ARNALL, GOLDEN GREGORY, LLP
|
|
|
|
|
|
Organized by:
|
|
Pharmaceutical Education Associates |
|
Invited Speakers:
|
|
Barbara R. Binis Partner REED SMITH, LLP Thomas M. Conroy Senior Regulatory Affairs ABBOTT LABORATORIES INC Jianefi Guo Co-Principal Investigator OHIO MEDICAID DRUG UTILIZATION REVIEW John Kamp Of Counsel WILEY REIN & FIELDING, LLP Daniel A. Kracov Partner PATTON BOGGS, LLP Arthur Levine Partner ARNOLD & PORTER Geoffrey Levitt Vice President & Chief Regulatory Counsel WYETH PHARMACEUTICALS William McGrath Partner WILEY REIN & FIELDING, LLP Alan G. Minsk Partner & Leader, Food and Drug Law ARNALL GOLDEN GREGORY, LLP
|
|
|
|
|
|
Deadline for Abstracts:
|
|
passed
|
|
|
|
|
|
Registration:
|
|
To register or to download a conference brochure go to www.pharmedassociates.com or call 800-686-2276
|
|
E-mail:
|
|
kcavin@pharmedassociates.com
|
|
|
|
|
|
|
|